Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,701-1,725 of 2,022
CompletedNCT04711460

Mindfulness, Group Therapy and Psychosis; Training Decreases Anxiety and Depression

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Global
Sponsor
University of Minnesota
Condition
Schizophrenia
CompletedNCT06231407

Increasing Medication Check Participation Through Applying CT-r

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Not Yet RecruitingNCT06208176

HD-tDCS for Hallucinations

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT03355781

Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Schizophrenia
CompletedNCT06206798

Resourcefulness Group Intervention on Recovery and Quality of Life

This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 20 Years to 64 Years
Countries
Taiwan
Sponsor
National Taipei University of Nursing and Health Sciences
Condition
Schizophrenia
CompletedNCT03309475

Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)

This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Spain
Sponsor
Instituto de Investigación Hospital Universitario La Paz
Condition
Schizophrenia
CompletedNCT05304780

Needs-tailored Nurse-led Recovery Program for Community-dwelling People With Schizophrenia

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 20 Years to 64 Years
Countries
Taiwan
Sponsor
National Taipei University of Nursing and Health Sciences
Condition
Schizophrenia
CompletedNCT06190483

Investigating the Role of Diazepam on Brain Function and Chemistry in Psychosis Risk

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Not Yet RecruitingNCT06184165

Stratifying Psychoses for Personalized REpetitive TMS in Persistent NEgative Symptoms Alleviation

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
Global
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
CompletedNCT04158687

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia

This study exists to understand whether the medication CTP-692 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication CTP-692 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Concert Pharmaceuticals
Condition
Schizophrenia
CompletedNCT03198078

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOtherFrom 13 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
TerminatedNCT06012981

Psychological Treatment in Psychiatric Inpatient Care

This study exists to improve how acceptance and commitment therapy, a talking treatment, can help identify, measure, or follow care over time. Researchers are trying to understand what acceptance and commitment therapy, a talking treatment, could change in day-to-day care and decision-making.

SchizophreniaOtherOver 18 Years
Countries
Sweden
Sponsor
Uppsala University
Condition
Schizophrenia
TerminatedNCT03318640

Mindfulness and Cognition in Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Schizophrenia
CompletedNCT04659161

A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
WithdrawnNCT03271814

Brain Biomarker on Inflammation Response

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 55 Years
Countries
Global
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT04783246

Virtual Group Fitness and Nutrition Intervention for Individuals With Psychosis

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Boston Medical Center
Condition
Schizophrenia
CompletedNCT04546178

Psychotherapy for Psychosis, Adverse Events, and Substance Misuse

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 19 Years to 35 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
TerminatedNCT04203056

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
Not Yet RecruitingNCT03543553

From Brain Currents to Interpersonal Flow: Investigating the Social Processing Stream of Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 17 Years to 55 Years
Countries
Global
Sponsor
Oslo University Hospital
Condition
Schizophrenia
CompletedNCT03859973

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Australia, Canada, France, New Zealand, United Kingdom, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
CompletedNCT05633108

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Eisai Co., Ltd.
Condition
Schizophrenia
CompletedNCT04442893

Exploring the Effect of Rumination-Focused Cognitive Behaviour Therapy in Patients With Schizophrenia

This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 20 Years to 65 Years
Countries
Taiwan
Sponsor
National Yang Ming Chiao Tung University
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research